EUVIMEDEUVIMED entdecken
Crossref

75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care

Seongbae Kong, Jeffrey Sobieraj, Frank Wang

Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB125

DOI: 10.1016/j.jaad.2026.04.508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von Seongbae Kong und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kong, S., Sobieraj, J., & Wang, F. (2026). 75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care. Journal of the American Academy of Dermatology, 95(1), AB125. https://doi.org/10.1016/j.jaad.2026.04.508

Vancouver

Kong S, Sobieraj J, Wang F. 75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care. Journal of the American Academy of Dermatology. 2026;95(1):AB125. doi:10.1016/j.jaad.2026.04.508

BibTeX
@article{Kong2026,
  author = {Kong, Seongbae and Sobieraj, Jeffrey and Wang, Frank},
  title = {75976 Concerns Regarding Dermatologic Side Effects Influencing Initiation and Dose of Testosterone Therapy in Gender Affirmation Care},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {AB125},
  doi = {10.1016/j.jaad.2026.04.508}
}
Kostenlos starten →